Sema4 in pact with Janssen re oncology trials
Sema4 has entered into a research agreement with Janssen Research & Development to optimize oncology clinical trials. Sema4 will provide Janssen access to two of...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Sema4 has entered into a research agreement with Janssen Research & Development to optimize oncology clinical trials. Sema4 will provide Janssen access to two of...
New Haven analytical pharmacy startup Valisure said it is teaming up with a national drug distributor in an effort to expand the reach of its...
Yale University has designated three independent laboratories to perform the university-developed SalivaDirect™ COVID-19 test. Along with Yale Pathology Labs — the first to offer the test...
Biohaven is in late-stage human testing of a nasal spray version of its migraine drug zavegepant (formerly vazegepant) … more Earlier this year the company reported that it had...
ReNetX Bio has added Dr. Kevin Malobisky to its Scientific Advisory Board. Dr. Malobisky, currently the Chief Regulatory and Strategic Operations Officer at Tavanta Therapeutics, brings over...
Shoreline Biome was recently awarded a patent for the “Combined Lysis Protocol for Comprehensive Cell Lysis.” The patent outlines the method and materials for the lysis of...
Pharmaceutical company Cara Therapeutics is expanding its Stamford headquarters by 11,685 square feet. more
Last June, Guilford-based Bioasis struck an agreement to license it s xB3 platform technology to the research giant Chiesi Group for the development of drugs...
Yale Engage, in conjunction with the Yale Cancer Center, presents the Yale Engage Cancer Series, an interactive webinar series, promoting impactful collaboration between academic experts...
BioCT invites your nominations for the 2020 Entrepreneur of the Year Award. The Entrepreneur of the Year Award was established by BioCT and Shipman and...